A significant federal policy change eliminated a major barrier to buprenorphine prescribing — worth understanding if you’ve encountered outdated information about needing a “specially certified” doctor.
What the X-waiver was: Previously, any provider wanting to prescribe buprenorphine for opioid use disorder needed a special federal waiver (under the Drug Addiction Treatment Act of 2000, hence “DATA-waiver” or “X-waiver”), which involved additional training and, for a long time, limits on how many patients a provider could treat.
What changed: The Consolidated Appropriations Act of 2023 eliminated the X-waiver requirement entirely. Any provider with a standard DEA registration that includes Schedule III authority can now prescribe buprenorphine for opioid use disorder, without the separate waiver or patient limits.
Why this matters for you practically: More providers — including many primary care doctors who previously didn’t have the waiver — can now prescribe buprenorphine. If you were told in the past that your doctor “couldn’t prescribe Suboxone,” that may no longer be true, and it’s worth asking again directly.
What didn’t change: Providers still need appropriate DEA registration, and some choose not to prescribe buprenorphine regardless of whether they’re legally permitted to, for various practice-related reasons — this removed a legal barrier, not a guarantee that every provider will offer it.
Medically reviewed by [pending]. Source: Consolidated Appropriations Act, 2023; DEA guidance on the elimination of the X-waiver.